irsogladine has been researched along with Helicobacter Infections in 3 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
Excerpt | Relevance | Reference |
---|---|---|
" pylori-positive gastric ulcer were given eradication treatment, then assigned randomly to a treatment group [given 4 mg/day irsogladine maleate (n = 150)] or a control group [given a placebo (n = 161)]." | 9.14 | Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study). ( Goto, H; Haruma, K; Hiraishi, H; Miwa, H, 2010) |
"Irsogladine has previously been shown to accelerate the healing of gastric ulcers after H." | 6.76 | Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. ( Abe, H; Arita, T; Fujioka, T; Kodama, M; Mizukami, K; Murakami, K; Okimoto, T; Shuto, M; Tanahashi, J, 2011) |
" pylori-positive gastric ulcer were given eradication treatment, then assigned randomly to a treatment group [given 4 mg/day irsogladine maleate (n = 150)] or a control group [given a placebo (n = 161)]." | 5.14 | Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study). ( Goto, H; Haruma, K; Hiraishi, H; Miwa, H, 2010) |
"Irsogladine, a mucosal protective drug, was developed in Japan for the treatment of peptic ulcer disease and acute gastritis." | 4.89 | Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract. ( Akagi, M; Amagase, K; Murakami, T; Takeuchi, K, 2013) |
"Irsogladine has previously been shown to accelerate the healing of gastric ulcers after H." | 2.76 | Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. ( Abe, H; Arita, T; Fujioka, T; Kodama, M; Mizukami, K; Murakami, K; Okimoto, T; Shuto, M; Tanahashi, J, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiraishi, H | 1 |
Haruma, K | 1 |
Miwa, H | 1 |
Goto, H | 1 |
Murakami, K | 1 |
Okimoto, T | 1 |
Kodama, M | 1 |
Tanahashi, J | 1 |
Mizukami, K | 1 |
Shuto, M | 1 |
Abe, H | 1 |
Arita, T | 1 |
Fujioka, T | 1 |
Akagi, M | 1 |
Amagase, K | 1 |
Murakami, T | 1 |
Takeuchi, K | 1 |
1 review available for irsogladine and Helicobacter Infections
Article | Year |
---|---|
Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract.
Topics: Animals; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Helicobacter Infec | 2013 |
2 trials available for irsogladine and Helicobacter Infections
Article | Year |
---|---|
Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study).
Topics: Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; | 2010 |
Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Topics: Aged; Alcohol Drinking; Anti-Ulcer Agents; Drug Administration Schedule; Famotidine; Female; Helicob | 2011 |